CN116508859A - Tea buccal tablet - Google Patents
Tea buccal tablet Download PDFInfo
- Publication number
- CN116508859A CN116508859A CN202310608599.6A CN202310608599A CN116508859A CN 116508859 A CN116508859 A CN 116508859A CN 202310608599 A CN202310608599 A CN 202310608599A CN 116508859 A CN116508859 A CN 116508859A
- Authority
- CN
- China
- Prior art keywords
- tea
- buccal tablet
- protein powder
- tea leaf
- mesh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 38
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 37
- 239000000843 powder Substances 0.000 claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 15
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 15
- 235000013615 non-nutritive sweetener Nutrition 0.000 claims abstract description 6
- 239000002826 coolant Substances 0.000 claims abstract description 5
- 239000000945 filler Substances 0.000 claims abstract description 5
- 239000000314 lubricant Substances 0.000 claims abstract description 5
- 241001122767 Theaceae Species 0.000 claims abstract 15
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 16
- 235000018102 proteins Nutrition 0.000 claims description 14
- 235000019359 magnesium stearate Nutrition 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 108010011485 Aspartame Proteins 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 7
- 108010073771 Soybean Proteins Proteins 0.000 claims description 7
- 239000000605 aspartame Substances 0.000 claims description 7
- 235000010357 aspartame Nutrition 0.000 claims description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 7
- 229960003438 aspartame Drugs 0.000 claims description 7
- 235000010356 sorbitol Nutrition 0.000 claims description 7
- 239000000600 sorbitol Substances 0.000 claims description 7
- 235000019710 soybean protein Nutrition 0.000 claims description 7
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 6
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical compound CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 claims description 6
- 229940041616 menthol Drugs 0.000 claims description 6
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 5
- 244000105624 Arachis hypogaea Species 0.000 claims description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 5
- 235000018262 Arachis monticola Nutrition 0.000 claims description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 5
- 229930195725 Mannitol Natural products 0.000 claims description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- 239000004376 Sucralose Substances 0.000 claims description 5
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical group [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 claims description 5
- 235000013539 calcium stearate Nutrition 0.000 claims description 5
- 239000008116 calcium stearate Substances 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 235000019477 peppermint oil Nutrition 0.000 claims description 5
- 229940013618 stevioside Drugs 0.000 claims description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 5
- 235000019202 steviosides Nutrition 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 5
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 4
- 239000004378 Glycyrrhizin Substances 0.000 claims description 4
- 108010084695 Pea Proteins Proteins 0.000 claims description 4
- 108010046377 Whey Proteins Proteins 0.000 claims description 4
- 102000007544 Whey Proteins Human genes 0.000 claims description 4
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 4
- 235000010358 acesulfame potassium Nutrition 0.000 claims description 4
- 229960004998 acesulfame potassium Drugs 0.000 claims description 4
- 239000000619 acesulfame-K Substances 0.000 claims description 4
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 4
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 4
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 4
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 4
- 235000019702 pea protein Nutrition 0.000 claims description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- 235000021119 whey protein Nutrition 0.000 claims description 4
- 239000000811 xylitol Substances 0.000 claims description 4
- 235000010447 xylitol Nutrition 0.000 claims description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 4
- 229960002675 xylitol Drugs 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000008103 glucose Substances 0.000 claims description 3
- 235000001727 glucose Nutrition 0.000 claims description 3
- 235000021552 granulated sugar Nutrition 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 235000019658 bitter taste Nutrition 0.000 abstract description 13
- 238000010791 quenching Methods 0.000 abstract description 4
- 235000019640 taste Nutrition 0.000 abstract description 4
- 230000035922 thirst Effects 0.000 abstract description 4
- 210000001124 body fluid Anatomy 0.000 abstract description 3
- 239000010839 body fluid Substances 0.000 abstract description 3
- 239000003205 fragrance Substances 0.000 abstract description 3
- 235000019629 palatability Nutrition 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 description 53
- 235000013616 tea Nutrition 0.000 description 48
- 239000007937 lozenge Substances 0.000 description 12
- 239000000463 material Substances 0.000 description 9
- 235000006468 Thea sinensis Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 7
- 235000020279 black tea Nutrition 0.000 description 6
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 5
- 235000005487 catechin Nutrition 0.000 description 5
- 108010038851 tannase Proteins 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- 235000009569 green tea Nutrition 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000001765 catechin Chemical class 0.000 description 2
- 235000015218 chewing gum Nutrition 0.000 description 2
- 229940112822 chewing gum Drugs 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000020344 instant tea Nutrition 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 235000020333 oolong tea Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000021332 multicellular organism growth Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 210000001779 taste bud Anatomy 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 235000020334 white tea Nutrition 0.000 description 1
- 235000020338 yellow tea Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/30—Further treatment of dried tea extract; Preparations produced thereby, e.g. instant tea
- A23F3/32—Agglomerating, flaking or tabletting or granulating
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Confectionery (AREA)
Abstract
The invention relates to a tea buccal tablet which is characterized by comprising 1% -30% of tea (calculated by dry matter), 0.1% -20% of protein powder, 0.1% -1% of non-nutritive sweetener, 0% -1% of cooling agent and the balance of filler and lubricant required by preparing the buccal tablet, wherein all percentages are weight percentages. The tea buccal tablet without bitter taste of tea provided by the invention has unique fresh and cool taste and fragrance, enables people to refresh and cool, refresh and refresh the brain, quench thirst and promote the production of body fluid, has good palatability, is convenient to take and carry, and is popular with consumers.
Description
Technical Field
The invention relates to a buccal tablet, in particular to a tea buccal tablet.
Background
Tea is the most popular beverage. The tea not only can quench thirst, but also has the effects of refreshing, building body, promoting digestion, resisting oxidation, eliminating free radicals, resisting aging and radiation, preventing and treating cancers, etc. Along with the development of technology, tea leaves gradually develop into various tea preparations such as teabags, instant tea and bottled tea beverages from the traditional tea making and taking modes. However, the teabag and instant tea are required to be drunk by water, and the bottled tea beverage has high manufacturing cost and inconvenient carrying. For this reason, some people succeed in developing tea buccal tablets, for example, patent CN1155386a "tea tablet and its preparation method", CN1653927a "a tea buccal tablet and its preparation method", CN101053352A "a tea buccal tablet and its preparation method", CN103652091a "a tea buccal tablet and its preparation method", and CN106804816a "a tea buccal tablet and its preparation method", all of which attempt to mask the bitter and astringent tastes of tea by adding sweeteners. However, the bitter taste of alkaloids and the bitter taste of tea polyphenols in tea leaves can not be well covered by only adding sweeteners when the buccal tablet is taken because of the longer contact time of the buccal tablet with taste buds in the tongue.
The invention patent CN102422914A 'high-protein tea lozenge' is characterized in that the tea powder, the protein powder or the milk powder and the walnut powder prepared by adopting an enzyme treatment process are composed, and the tannase is called as tannase which can degrade ester catechin with heavy bitter taste into simple catechin, so that the bitter taste of tea is reduced: CN106538740a 'a black tea lozenge and a preparation method thereof', which is characterized in that the black tea lozenge is composed of tea powder, protein powder or milk powder, american ginseng powder and tea aromatic oil which are prepared by enzyme treatment, and the tannase treatment is purported to be helpful for reducing the content of ester catechin and eliminating bitter taste. Although tannase treatment helps to reduce the content of ester-type catechins and reduce the bitter taste of ester-type catechins, it does not improve the bitter taste of alkaloids in tea leaves.
Disclosure of Invention
The invention aims to solve the technical problem of providing the tea buccal tablet which has no bitter taste of tea and good taste. The tea buccal tablet without bitter taste of tea provided by the invention has unique fresh and cool taste and fragrance, enables people to refresh and cool, refresh and refresh the brain, quench thirst and promote the production of body fluid, has good palatability, is convenient to take and carry, and is popular with consumers.
In order to solve the technical problems, the invention adopts the following technical scheme: the tea buccal tablet consists of 1% -30% of tea (calculated by dry matter), 0.1% -20% of protein powder, 0.1% -1% of non-nutritive sweetener, 0% -1% of cooling agent, and the balance of filler and lubricant required for preparing the buccal tablet, wherein all percentages are weight percentages.
The tea is fine powder of 100 meshes and above, and/or water extract of tea.
The protein powder is 100 mesh or above protein powder, and comprises one or mixture of soybean protein powder, peanut protein powder, pea protein powder, whey protein powder, etc.
The non-nutritive sweetener is one or a mixture of sucralose, aspartame, acesulfame potassium, stevioside, glycyrrhizin and the like.
The cooling agent is one or a mixture of menthol, peppermint oil, N-ethyl-2-isopropyl-5-methylcyclohexane formamide (WS-3), N,2, 3-trimethyl-2-isopropyl butyramide (WS-23) and the like.
The filler is any one or mixture of white sugar, lactose, glucose, mannitol, sorbitol and xylitol.
The lubricant is calcium stearate or magnesium stearate.
The beneficial effects are that: the invention surprisingly discovers that when 0.1% -20% of protein powder, 0.1% -1% of non-nutritive sweetener and 1% -30% of tea are combined, the bitter taste of the tea is avoided, the unique fresh and cool taste and fragrance are presented, people can refresh the mind and feel refreshing, refresh the mind and quench thirst and promote the production of body fluid, and the novel formula tea buccal tablet has good palatability and is very popular with consumers. Meanwhile, proteins are one of essential nutrients essential to the human body, and are necessary for maintaining and repairing the body and cell growth.
Description of the embodiments
The present invention will be described in detail with reference to specific examples. Of course, according to the technical proposal of the invention, the ordinary person skilled in the food industry can prepare the mouthpieces such as tea candy or tea chewing gum without the bitter taste of tea according to the manufacturing technology of ordinary candy or chewing gum.
Example 1
A tea buccal tablet is composed of the following materials in parts by weight: 280 g of 800-mesh green tea fine powder, 20 g of green tea water extract, 200 g of 300-mesh soybean protein powder, 10 g of aspartame, 5 g of menthol, 5 g of peppermint oil, 475 g of white granulated sugar and 5 g of magnesium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 2
A tea buccal tablet is composed of the following materials in parts by weight: 60 g of 500-mesh black tea powder, 40 g of 400-mesh oolong tea powder, 90 g of 120-mesh peanut protein powder, 10 g of 180-mesh whey protein powder, 5 g of aspartame, 1 g of peppermint oil, 790 g of sorbitol and 4 g of magnesium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 3
A tea buccal tablet is composed of the following materials in parts by weight: 100 g of 300 mesh oolong tea powder, 52 g of 100 mesh pea protein powder, 5 g of stevioside, 3 g of acesulfame potassium, 2 g of glycyrrhizin, 2 g of menthol, 1 g of peppermint oil, 830 g of glucose and 5 g of calcium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 4
A tea buccal tablet is composed of the following materials in parts by weight: 10 g of 500-mesh jasmine tea powder, 1 g of 200-mesh whey protein powder, 5 g of sucralose, 0.5 g of WS-3, 700 g of xylitol, 279 g of sorbitol and 4.5 g of magnesium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 5
A tea buccal tablet is composed of the following materials in parts by weight: 5 g of 200-mesh black tea fine powder, 5 g of black tea water extraction dry matter, 18 g of 150-mesh peanut protein powder, 10 g of 200-mesh pea protein powder fine powder, 3 g of stevioside, 2 g of sucralose, 1.8 g of menthol, 0.1 g of WS-23, 0.1 g of WS-3, 950 g of lactose and 5 g of calcium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 6
A tea buccal tablet is composed of the following materials in parts by weight: 10 g of 400-mesh white tea powder, 1 g of 100-mesh soybean protein powder, 1 g of sucralose, 885 g of sorbitol, 100 g of mannitol and 3 g of magnesium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 7
A tea buccal tablet is composed of the following materials in parts by weight: 50 g of 500-mesh green tea powder, 7 g of 400-mesh soybean protein powder, 3 g of aspartame, 1 g of stevioside, 1 g of glycyrrhizin, 1 g of menthol, 0.3 g of WS-23, 800 g of white granulated sugar, 130 g of mannitol and 6.7 g of calcium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 8
A tea buccal tablet is composed of the following materials in parts by weight: 50 g of 300-mesh black tea powder, 10 g of 300-mesh soybean protein powder, 5 g of 300-mesh peanut protein powder, 5 g of acesulfame potassium, 5 g of aspartame, 500 g of sorbitol, 300 g of xylitol, 120 g of mannitol and 5 g of magnesium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Example 9
A tea buccal tablet is composed of the following materials in parts by weight: 50 g of 200-mesh yellow tea powder, 5 g of 200-mesh soybean protein powder, 1 g of aspartame, 0.5 g of WS-3, 939 g of sorbitol and 4.5 g of magnesium stearate; the components are respectively prepared according to food-grade requirements, and then the components are prepared by adopting the production process of a common lozenge according to the weight ratio.
Claims (7)
1. The tea buccal tablet is characterized by comprising 1% -30% of tea (calculated by dry matter), 0.1% -20% of protein powder, 0.1% -1% of non-nutritive sweetener, 0% -1% of cooling agent and the balance of filler and lubricant required by preparing the buccal tablet, wherein all percentages are weight percentages.
2. A tea leaf buccal tablet according to claim 1 wherein the tea leaves are tea leaf fines of 100 mesh and above, and/or tea leaf water extracts.
3. A tea leaf buccal tablet according to claim 1 wherein the protein powder is 100 mesh or above and comprises one or a mixture of soybean protein powder, peanut protein powder, pea protein powder, whey protein powder, etc.
4. The tea leaf buccal tablet of claim 1, wherein the non-nutritive sweetener used for preparing the buccal tablet is one or a mixture of sucralose, aspartame, acesulfame potassium, stevioside, glycyrrhizin and the like.
5. A tea leaf buccal tablet according to claim 1, wherein the cooling agent is one of menthol, peppermint oil, N-ethyl-2-isopropyl-5-methylcyclohexane carboxamide (WS-3), N,2, 3-trimethyl-2-isopropyl butyramide (WS-23) or the like or a mixture thereof.
6. A tea leaf buccal tablet according to claim 1 wherein the filler is selected from any one or a mixture of white granulated sugar, lactose, glucose, mannitol, sorbitol, xylitol.
7. A tea leaf buccal tablet according to claim 1 wherein the lubricant used to prepare the buccal tablet is calcium stearate or magnesium stearate.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310608599.6A CN116508859A (en) | 2023-05-28 | 2023-05-28 | Tea buccal tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202310608599.6A CN116508859A (en) | 2023-05-28 | 2023-05-28 | Tea buccal tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116508859A true CN116508859A (en) | 2023-08-01 |
Family
ID=87408341
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202310608599.6A Pending CN116508859A (en) | 2023-05-28 | 2023-05-28 | Tea buccal tablet |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116508859A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1155386A (en) * | 1996-12-11 | 1997-07-30 | 樊华轩 | Tea flakes and their production |
| CN102422914A (en) * | 2011-11-02 | 2012-04-25 | 江苏省农业科学院 | High-protein tea lozenge |
| CN107242556A (en) * | 2017-05-25 | 2017-10-13 | 四川农业大学 | A kind of dual-purpose FLOS CHRYSANTHEMI ALBA from Haizhou of China lozenge and preparation method thereof |
| CN107821670A (en) * | 2016-09-15 | 2018-03-23 | 樊华轩 | A kind of tealeaves buccal tablet |
-
2023
- 2023-05-28 CN CN202310608599.6A patent/CN116508859A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1155386A (en) * | 1996-12-11 | 1997-07-30 | 樊华轩 | Tea flakes and their production |
| CN102422914A (en) * | 2011-11-02 | 2012-04-25 | 江苏省农业科学院 | High-protein tea lozenge |
| CN107821670A (en) * | 2016-09-15 | 2018-03-23 | 樊华轩 | A kind of tealeaves buccal tablet |
| CN107242556A (en) * | 2017-05-25 | 2017-10-13 | 四川农业大学 | A kind of dual-purpose FLOS CHRYSANTHEMI ALBA from Haizhou of China lozenge and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8088429B2 (en) | Package drink | |
| US6723369B2 (en) | Carbonated beverage for strengthening acid resistancy of teeth | |
| JP3378577B1 (en) | Drink | |
| JP4569965B2 (en) | Method for producing purified green tea extract | |
| EP1472932B1 (en) | Process for producing green tea polyphenol | |
| EP2082651B1 (en) | Beverage packed in container | |
| TWI492715B (en) | Containing polymerized catechins | |
| US20090104337A1 (en) | Process for producing purified green tea extract | |
| JP5681262B1 (en) | Tea drink | |
| US10154999B2 (en) | Caffeinated gummies | |
| JP6184693B2 (en) | Tea drink and method for producing the same | |
| CN116508859A (en) | Tea buccal tablet | |
| JP2012191950A (en) | Stable and consumable composition | |
| CN114867355A (en) | Green tea beverage with enhanced flavor | |
| JP2004222640A (en) | Method for preventing precipitation of drink containing polyphenol | |
| JP2003171297A (en) | Blood bilirubin concentration depressant and medicine for treatment/prevention of jaundice | |
| CN113749203A (en) | Beverage with weight reducing effect and preparation method thereof | |
| JP2004173504A (en) | Method for preventing precipitation of beverage | |
| WO2019082547A1 (en) | Tea-flavor-improving agent and packaged tea beverage containing same | |
| CN107821670A (en) | A kind of tealeaves buccal tablet | |
| CN117119899A (en) | Energy beverage composition and method for producing same | |
| CN117794393A (en) | Oral compositions | |
| JP2024034745A (en) | Packed black tea beverage and method for producing the same | |
| JP2024034744A (en) | Packed black tea beverage and method for producing the same | |
| JP4840003B2 (en) | Oral composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |